Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.590
+0.020 (1.27%)
At close: Feb 17, 2026, 4:00 PM EST
1.620
+0.030 (1.89%)
After-hours: Feb 17, 2026, 7:43 PM EST
Equillium Market Cap
Equillium has a market cap or net worth of $96.82 million as of February 17, 2026. Its market cap has increased by 314.04% in one year.
Market Cap
96.82M
Enterprise Value
64.45M
1-Year Change
314.04%
Ranking
Category
Stock Price
$1.59
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $96.82M, a decrease of -58.72%. That is a compound annual growth rate of -11.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 95.60M | 1.29% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dogwood Therapeutics | 102.22M |
| Cassava Sciences | 100.96M |
| Actuate Therapeutics | 100.64M |
| Agenus | 99.30M |
| Cognition Therapeutics | 98.87M |
| Artiva Biotherapeutics | 98.18M |
| Vivani Medical | 94.23M |
| Anixa Biosciences | 94.13M |